Equity Overview
Price & Market Data
Price: $3.65
Daily Change: -$1.37 / 37.53%
Range: $0 - $0
Market Cap: $92,981,944
Volume: 0
Performance Metrics
1 Week: -27.29%
1 Month: -27.29%
3 Months: 81.60%
6 Months: 128.1%
1 Year: 4.29%
YTD: -36.85%
Details
RetinalGeniX Technologies Inc., an ophthalmic research and development company, focuses on developing technologies to screen, monitor, diagnose, and treat ophthalmic, optical, and sight-threatening disorders. Its products include the Retinal Imaging Screening Device, a portable retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCam, an in-home/remote location patient-activated monitoring and imaging device offering real-time communication and alerting system for physicians. It also develops RTG-2023 for the treatment of dry age-related macular degeneration; and RTG-2024 for the treatment of Alzheimer's syndrome dementia. The company was incorporated in 2017 and is based in Apollo Beach, Florida. RetinalGenix Technologies Inc. is a subsidiary of Sanovas Ophthalmology, LLC.